Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol — Stella

Recruiting

Back to IVF trials

Trial locations(1 site)

Israel

Hillel Yaffe Medical Center, Hadera

Key details

Sponsor

Hillel Yaffe Medical Center

Enrollment target

~120 participants

Started

August 2022

Primary completion

December 2027

Age range

18 Years – 41 Years

Sex

Female only

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov